Literature DB >> 5075327

Limitations of lignocaine in control of early ventricular dysrhythmias complicating acute myocardial infarction.

J S Geddes, S Webb, J F Pantridge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5075327

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  6 in total

1.  The clinical pharmacology of lidocaine as an antiarrhythmic drug.

Authors: 
Journal:  West J Med       Date:  1976-01

Review 2.  Therapeutic drug monitoring of antiarrhythmic drugs. Rationale and current status.

Authors:  R Latini; A P Maggioni; A Cavalli
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

3.  Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmia complicating acute myocardial infarction.

Authors:  L Rydén; A Waldenström; L Ehn; S Holmberg; M Husaini
Journal:  Br Heart J       Date:  1973-11

Review 4.  Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.

Authors:  C P Denaro; N L Benowitz
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 5.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

6.  Observations on intravenous administration of lignocaine in patients with myocardial infarction.

Authors:  N P Campbell; J G Kelly; A A Adgey; D G McDevitt; J F Pantridge
Journal:  Br Heart J       Date:  1978-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.